Prosecution Insights
Last updated: August 18, 2026

Miltenyi Biotec B.V. & Co. KG

13 pending office actions • 9 art units • 11 examiners • 0 of 13 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Portfolio Summary

13
Total Pending OAs
9
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (38%)
4
Medium (31%)
4
Easy (31%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (15%)
§112 only3 (23%)
Double-patenting only1 (8%)
Double-patenting + other2 (15%)
Multi-statute (no §101)5 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
92% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
8% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

130 h
Manual time on pending OAs
26 h
Time saved (low, 20%)
46 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GAO, ASHLEY HARTMAN 2 57.5% +42.4%
HAQ, SHAFIQUL 2 65.0% +55.1%
NGUYEN, THONG Q 1 67.6% +12.1%
KAPUSHOC, STEPHEN THOMAS 1 46.7% +53.2%
SCHLOOP, ALLISON ELIZABETH 1 58.5% +60.8%
OGUNTADE, ELIZABETH BISOLA 1 0.0% +0.0%
PHAM, KHAI QUYNH TIEN 1 0.0% +0.0%
BUNNER, BRIDGET E 1 64.4% +20.0%
GREENE, CAROLYN LEE 1 64.9% +49.7%
DU, SURBHI M 1 68.1% +27.7%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18024603 CONJUGATES HAVING AN ENZYMMATICALLY RELEASABLE DETECTION MOIETY AND A BARCODE MOIETY GAO, ASHLEY HARTMAN 17d overdue
18280706 ARTIFICIAL TARGET FOR ANTIGEN-SPECIFIC ACTIVATION AND EXPANSION OF CAR T CELLS OGUNTADE, ELIZABETH BISOLA 9d
18572107 UNIT-DNA COMPOSITION FOR SPATIAL BARCODING AND SEQUENCING KAPUSHOC, STEPHEN THOMAS
18274541 Method for Library Preparation in Next Generation Sequencing by Enzymatic DNA Fragmentation PHAM, KHAI QUYNH TIEN
17799870 Method for providing personalized cells with chimeric antigen receptors (CAR) against tumor microenvironment cells STAVROU, CONSTANTINA E

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18024603 CONJUGATES HAVING AN ENZYMMATICALLY RELEASABLE DETECTION MOIETY AND A BARCODE MOIETY GAO, ASHLEY HARTMAN 17d overdue
18657878 METHOD AND APPARATUS FOR HIGH RESOLUTION MICROSCOPY NGUYEN, THONG Q
18572107 UNIT-DNA COMPOSITION FOR SPATIAL BARCODING AND SEQUENCING KAPUSHOC, STEPHEN THOMAS
18373441 GENE SPECIFIC TISSUE INFORMATION AND SEQUENCING SCHLOOP, ALLISON ELIZABETH
18369273 BIOLOGICAL CONJUGATES HAVING AN PHOTOGENERATED ACIDIC OR BASIC RELEASABLE DETECTION MOIETY ON TOP OF BIOLOGICAL TISSUES GAO, ASHLEY HARTMAN
18035356 Methods and compositions for eliminating engineered immune cells BUNNER, BRIDGET E
18307406 EX-SITU SEQUENCING OF RCA PRODUCT GENERATED IN-SITU GREENE, CAROLYN LEE
18097244 Water-soluble M-conjugated fluorescent 1,1-binaphthyl-based tandem polymers HAQ, SHAFIQUL

Top Art Units

Art UnitApps
1678 4
1683 2
2872 1
1677 1
1684 1
1647 1
1681 1
1765 1
1632 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18657878 METHOD AND APPARATUS FOR HIGH RESOLUTION MICROSCOPY NGUYEN, THONG Q 2872 §112 Non-Final OA Pending May 08, 2024
18572107 UNIT-DNA COMPOSITION FOR SPATIAL BARCODING AND SEQUENCING KAPUSHOC, STEPHEN THOMAS 1683 §102§103§112 Non-Final OA Pending Dec 19, 2023
18373441 GENE SPECIFIC TISSUE INFORMATION AND SEQUENCING SCHLOOP, ALLISON ELIZABETH 1683 §112 Final Rejection Pending Sep 27, 2023
18369273 BIOLOGICAL CONJUGATES HAVING AN PHOTOGENERATED ACIDIC OR BASIC RELEASABLE DETECTION MOIETY ON TOP OF BIOLOGICAL TISSUES GAO, ASHLEY HARTMAN 1678 DP Non-Final OA Pending Sep 18, 2023
18280706 ARTIFICIAL TARGET FOR ANTIGEN-SPECIFIC ACTIVATION AND EXPANSION OF CAR T CELLS OGUNTADE, ELIZABETH BISOLA 1677 §103§112 Final Rejection 9d Pending Sep 07, 2023
18274541 Method for Library Preparation in Next Generation Sequencing by Enzymatic DNA Fragmentation PHAM, KHAI QUYNH TIEN 1684 §102§103 Non-Final OA Pending Jul 27, 2023
18035356 Methods and compositions for eliminating engineered immune cells BUNNER, BRIDGET E 1647 §103 Non-Final OA Pending May 04, 2023
18307406 EX-SITU SEQUENCING OF RCA PRODUCT GENERATED IN-SITU GREENE, CAROLYN LEE 1681 §112 Final Rejection Pending Apr 26, 2023
18024603 CONJUGATES HAVING AN ENZYMMATICALLY RELEASABLE DETECTION MOIETY AND A BARCODE MOIETY GAO, ASHLEY HARTMAN 1678 §103§112Other Non-Final OA 17d overdue Pending Mar 03, 2023
18097244 Water-soluble M-conjugated fluorescent 1,1-binaphthyl-based tandem polymers HAQ, SHAFIQUL 1678 §103§112DP Non-Final OA Pending Jan 15, 2023
18097243 WATER-SOLUBLE II-CONJUGATED FLUORESCENT 1,1 -BINAPHTHYL-BASED POLYMERS WITH TUNEABLE ABSORPTION HAQ, SHAFIQUL 1678 §102§103§112DP Non-Final OA Pending Jan 15, 2023
18015351 FLUORESCENT DYES COMPRISING M-CONJUGATED 1,1 -BINAPHTHYL-BASED POLYMERS DU, SURBHI M 1765 §103Other Final Rejection Pending Jan 10, 2023
17799870 Method for providing personalized cells with chimeric antigen receptors (CAR) against tumor microenvironment cells STAVROU, CONSTANTINA E 1632 §103§112Other Non-Final OA Pending Aug 15, 2022

Managing Miltenyi Biotec B.V. & Co. KG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month